JBC DNA damage antibodies

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M608717200 on January 4, 2007

J. Biol. Chem., Vol. 282, Issue 12, 9143-9149, March 23, 2007
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/12/9143    most recent
M608717200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lagerstedt, J. O.
Right arrow Articles by Voss, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lagerstedt, J. O.
Right arrow Articles by Voss, J. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Electron Paramagnetic Resonance Spectroscopy of Site-directed Spin Labels Reveals the Structural Heterogeneity in the N-terminal Domain of ApoA-I in Solution*

Jens O. Lagerstedt{ddagger}§1, Madhu S. Budamagunta{ddagger}, Michael N. Oda, and John C. Voss{ddagger}2

From the Departments of {ddagger}Biochemistry and Molecular Medicine and §Internal Medicine, University of California, Davis, California 95616 and the Children's Hospital Oakland Research Institute, Oakland, California 94609-1673

Received for publication, September 11, 2006 , and in revised form, December 21, 2006.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Apolipoprotein A-I (apoA-I) is the major protein constituent of high density lipoprotein (HDL) and plays a central role in phospholipid and cholesterol metabolism. This 243-residue long protein is remarkably flexible and assumes numerous lipid-dependent conformations. Consequently, definitive structural determination of lipid-free apoA-I in solution has been difficult. Using electron paramagnetic spectroscopy of site-directed spin labels in the N-terminal domain of apoA-I (residues 1-98) we have mapped a mixture of secondary structural elements, the composition of which is consistent with findings from other insolution methods. Based on side chain mobility and their accessibility to polar and non-polar spin relaxers, the precise location of secondary elements for amino acids 14-98 was determined for both lipid-free and lipid-bound apoA-I. Based on intermolecular dipolar coupling at positions 26, 44, and 64, these secondary structural elements were arranged into a tertiary fold to generate a structural model for lipid-free apoA-I in solution.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
High density lipoprotein (HDL)3 plays a central role in lipid metabolism as a principal facilitator of reverse cholesterol transport, a process wherein cholesterol is mobilized from peripheral tissues and delivered to the liver and steroidogenic organs. Low levels of HDL represent a major risk factor for cardiovascular disease, and there is growing interest in therapies that can enhance HDL plasma levels or its anti-atherogenic activity (1).

Apolipoprotein A-I (apoA-I) comprises ~70% of the protein content of HDL and is a primary determinant of HDL structure, composition, and stability. ApoA-I is a prominent member of the exchangeable apolipoprotein class of proteins, and HDL derives a large portion of its functionality from the ability of apoA-I to sequester phospholipid and cholesterol and functionally interact with plasma enzymes and cellular receptors (for a recent review see Ref. 2).

In a previous study, we applied site-directed spin label electron paramagnetic resonance (SDSL-EPR) spectroscopy to determine the conformation of the C-terminal domain of apoA-I (3). This approach allowed us to both describe the structure of the lipid-free apoA-I C terminus (residues 163-241) and also report on the structural changes that arise because of lipidation. Using a similar approach, we have targeted the N-terminal one-third of apoA-I to identify regions of conformational flexibility and sites of inter- and intramolecular interaction. The unique genetic (4, 5), pathophysiological (6, 7), and structural (8, 9) features associated with the N terminus highlight the need to ascertain the structure and dynamics of this region of apoA-I in the presence and absence of lipid.

The present SDSL-EPR analysis of residues 14-98 of fulllength apoA-I reveals a mixed secondary structure composition for this region. We also identify sites of more stable tertiary interactions in an otherwise conformational dynamic segment of the protein. To observe the effect of lipid binding on the structure of the N terminus, the spin-labeled samples were analyzed in reconstituted HDL discs, providing insight into the adaptive response that the secondary structure of apoA-I undergoes during lipidation.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Materials—Thio-specific nitroxide spin label (1-oxyl-2,2,5,5-tetramethylpyrroline-3-methyl)methanethiosulfonate (MTS-SL) was received as a kind gift from Dr. K. Hideg (University of Pecs, Hungary). Standard molecular biology procedures were used to create the different plasmid constructs. All mutagenic primers were purchased from Sigma-Genosys (The Woodlands, TX), and Davis Sequencing (Davis, CA) performed DNA sequence determination.


Figure 1
View larger version (40K):
[in this window]
[in a new window]

 
FIGURE 1.
Secondary structure analysis of the N-terminal domain of lipid-free apoA-I. A, single-cysteine apoA-I mutants (residue 14-98) are spin-labeled and analyzed by EPR. The spectra describe the local environment of the individually spin-labeled residues. Residues Val-30 and Val-53 are examples of positions where the spin label either has a high degree of immobilization (Val-30) or exhibits a high motional freedom (Val-53). B, accessibility parameters for polar (prodCrOx, filled circles) and non-polar (prodO2, open squares), and the side chain mobility ({delta}-1, filled squares) are plotted versus residue number. The regions displaying {alpha}-helical character are highlighted in green, and beta-structure is shown in purple. The unusually high O2 collision frequency at Val-67 may arise from its location in a relatively non-polar open cleft. C, the schematic linear presentation of the secondary structure for residues 14-98 uses the same color code for {alpha}-helix and beta-structure as in D. Loops (and a kink at Gly-65/Pro-66) are shown in pink. D, the amphipathic nature of the experimentally determined {alpha}-helical segments is shown in the helical wheel analyses (3.6 residues/turn). The color code is black for hydrophobic (Met, Ile, Leu, Val, Phe, Tyr, Trp, Ala), orange for polar and uncharged (Ser, Thr, Asn, Gln), red for negatively charged (D, E), blue for positively charged (Lys, His, Arg) residues, and green for glycine (Gly) residues.

 
Construction, Expression, Purification, and MTS Labeling of ApoA-I Mutants—PCR mutagenesis was applied on an apoA-I template enhanced for bacterial expression (10). Dideoxy DNA sequencing confirmed the substitutions and the absence of unwanted changes. The resulting constructs expressed apoA-I mutant proteins with single substitutions of the native amino acids for cysteines, and the mutants were purified and labeled with MTS-SL as described previously (3). Briefly, the apoA-I protein was sequentially incubated with 100 µM Tris-(2-carboxyethyl)phosphine and 300 µM MTS spin label on a Ni2+-chelated HiTrap column (GE Healthcare) under denaturing conditions (3 M guanidine-HCl). The protein purity was estimated higher than 95% by SDS-polyacrylamide gel electrophoresis analysis and Coomassie Brilliant Blue staining. The protein concentration was determined by use of the MicroBCA assay kit from Pierce (Rockford, IL). Bovine serum albumin was used as a standard.

ApoA-I Lipidation—Reconstituted nascent HDL were prepared by a modified method originally described by Nichols et al. (11, 12). To 0.5 ml of 16.3 mM 1-palmitoyl-2-oleoyl-sn-glycerophosphocholine (POPC) in TBS, pH 8 was added an equal volume of TBS, pH 8, 22 mM sodium deoxycholate. The mixture was vortexed and incubated at 37 °C until completely clear. 3 mg of spin-labeled apoA-I was added to the cleared dispersion (1:2.04 w/w apoA-I:POPC) and incubated for 1 h at 37 °C. Deoxycholate was removed by extensive dialysis against TBS, pH 8. Reconstituted nascent HDL was recovered by KBr density gradient ultracentrifugation at 50,000 x g for 3 h in a Beckman Optima TLA 100.4 rotor. Fractions containing both protein and lipid were pooled and dialyzed against TBS, pH 7.4. The size of lipidated discoidal complexes was confirmed by gradient gel electrophoresis (11).

EPR Analysis—EPR measurements were carried out in a JEOL X-band spectrometer fitted with a loop-gap resonator (13, 14). For room temperature spectra, an aliquot (5 µl) of purified, spin-labeled protein (100 µM) was placed in a sealed quartz capillary contained in the resonator. Spectra were acquired at room temperature (20-22 °C) from a single 60-s scan over a field of 100 G at a microwave power of 2 milliwatt and a modulation amplitude optimized to the natural line width of the individual spectrum (0.5-1.5 G). The spectra were normalized by the intensity of their integrals. For frozen spectra (-100 °C), samples were first flash-frozen in sealed capillaries by rapid immersion into a butane bath cooled in liquid nitrogen. Samples were then placed in a TE cavity and scanned over 100 G using a microwave power of 0.1 milliwatt and modulation width of 1 G.

Molecular accessibility of spin-labeled side chains to chromium oxalate (CrOx) and O2 was determined using successive power saturation scans as described (15). prod1/2 values (which also were used to calculate the contrast function ({Phi})) were calculated using software provided by C. Altenbach.

Molecular Modeling—Insight II software (version 2005) on the Octane work station by Silicon Graphics was used for structural modeling. The protein data bank coordinates of crystalline lipid-free apoA-I (code 2A01) (16) were used as templates.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
SDSL-EPR Analysis of Lipid-free ApoA-I—The chemical and structural properties of the N-terminal one-third of apoA-I were examined by EPR spectroscopy. Here, 82 individual cysteine substitution mutants of apoA-I were created between residues 14 and 98.4 These 82 cysteine substitution variants of apoA-I were expressed in bacteria, purified, and labeled at the cysteine sulfhydryl with nitroxide label. The EPR spectra obtained from these protein samples (Fig. 1A) reported on the immediate milieu of the labeled side chains. Strong immobilization of the side chain is observed as spectral broadening (for example, see spectra for V30C and L75C in Fig. 1A), whereas a high degree of side chain motional freedom is characterized by a sharpness of the spectra (Fig. 1A, G35C and V53C spectra). The inverse central line width ({delta}-1, Gauss-1), a parameter that directly reflects the side chain mobility (17), was used to determine the secondary structure (Fig. 1B, bottom). In addition, the collision frequency between the nitroxide on the labeled side chain and the polar or non-polar relaxation agents (chromium oxalate (CrOx) and oxygen (O2), respectively) was used to determine the accessibility (prod; Fig. 1B, upper graph) of the respective compound and thus also the chemical environment at the side chain. Based on the periodicity (generated from asymmetrical solvent or tertiary contacts) of these values, several regions were identified as {alpha}-helical with a helical pitch of 3.6 residues/turn.

For example, residues 26-34 display an {alpha}-helical pattern with a periodicity between 3 and 4 for both the mobility and accessibility parameters. This can be seen in the EPR spectra of residues 26, 30, 33, and 34, the line shapes of which display immobilized, broadened features. The intervening residues exhibit more mobile spectra, and their prod-values indicate they are in a more hydrophilic environment. Moreover, the residues with immobilized spectra are concentrated within a hydrophobic region in the helical wheel plot (Fig. 1D). The same approach was used to identify other {alpha}-helical regions. These are comprised of residues 36-42, 44-51, 55-85, and residues 92-98 (Fig. 1, B-D). Of these segments, the mobility parameter for residues 36-42 do not exhibit this periodicity, suggesting a more complex modulation of side chain dynamics in this region. However, the accessibility of the relaxation agents for these residues bears a helical periodicity, allowing for an assignment of helical secondary structure for residues 36-42.

In addition, residues 20-25 bore an alternating periodicity of mobility consistent with beta-strand structure. This conclusion is also supported by the non-polar accessibility parameter for this stretch of amino acids (Fig. 1B, prodO2). The mobility parameter for residues 87-92 also demonstrates such a periodicity. However, because the accessibility data for this region do not support such a pattern and also because the overall mobility is high, we propose this region to be a loop; although the presence of beta-strand structure cannot be completely excluded.


Figure 2
View larger version (20K):
[in this window]
[in a new window]

 
FIGURE 2.
Dipolar coupling between spin-labeled residues in apoA-I dimers. A, the EPR spectra from spin labels at residues 26, 44, 64 (this study), and 167 (3) indicate dipolar coupling between residues on two dimerized apoA-I molecules. B, frozen spectra were used to calculate the d1/d line height ratio.

 
In contrast to the clearly defined structural regions of the N-terminal third of apoA-I, there are segments of this region that appear unstructured (Fig. 1B, white). These loop regions typically exhibit spectra with high mobility and are also readily accessible by EPR relaxation agents. For example, the line shapes for spectra 51-55 are sharp with high {delta}-1 values (>0.4 Gauss-1). In particular, position 53 exhibits a spectrum that is similar in appearance to the spectra of unbound nitroxide. These residues thus clearly define a loop region. Similarly, the spectra of nitroxides at residues 35 and 43 also display high mobility, which does not fit with the helical pattern of the neighboring residues. Thus, residues 35 and 43 may also represent interruptions in the regular helical structure. By the same criteria, residues 86 to 91 have been assigned coil/turn secondary structure. The final assignment of secondary structure is summarized in Fig. 1C.

Several of the EPR spectra of lipid-free apoA-I display a broadening (Fig. 2) indicative of dipolar coupling between two nitroxides. For proteins labeled with only one disulfide-linked nitroxide, the dipolar interaction must be intermolecular. At the concentrations of apoA-I used in this study, the quaternary state of apoA-I exists as a dynamic equilibrium between monomers, dimers, and higher order oligomers (18). Because of the limited range in which dipolar broadening is observable (<20 Å) by continuous wave EPR and the small subset of residues, which exhibit dipolar spin coupling, we assign residues 26, 44, and 64 within the central plane of an antiparallel dimer. Further evaluation of the broadening as a function of the distance-dependent dipolar interaction was performed by collecting the EPR spectra of frozen samples. In the absence of motion (i.e. frozen in liquid N2), a semiquantitative analysis of the extent of broadening because of dipolar interaction can be obtained from the d1/d spectral ratio (19, 20) (Fig. 2B). All four examined positions reveal a d1/d ratio between 0.38 and 0.41, confirming a weak dipolar coupling and therefore the close proximity of spin labels in the self-associated population. This alignment of amino acids allows for the synthesis of a tertiary model in which segments of secondary structure containing sites of self-interaction can be aligned relative to the central plane of the protein (3).

SDSL-EPR Analysis of Lipid-bound ApoA-I—ApoA-I undergoes major structural changes as it binds lipids. During this process the helical structure content increases from 45-58% (21) to ~80% for lipid-bound apoA-I (22). To examine the structural consequences of lipid binding, the spin-labeled apoA-I protein preparations described above were utilized in the formation of recombinant HDL. This allowed for a direct comparison of the EPR spectra of the N-terminal domain in two environmentally distinct states. Clearly, a majority of nitroxide-labeled side chains experienced a higher steric hindrance in the lipid-bound state compared with the lipid-free state. This is typified by generally broader spectral shapes for lipid-bound forms of the protein (Fig. 3A). The exceptions include positions Ser-31, Thr-56, and Leu-64, which all display an increased mobility in the lipid-bound state, whereas some side chains, such as Leu-42 and Arg-83, appear to be structurally unaffected.

To define the helical faces in the apoA-I N terminus relative to lipid, the contrast function ({Phi}), which reflects the ratio between the accessibility parameters for O2 and CrOx (Fig. 3B). This value is especially useful for membrane-embedded proteins and lipoproteins because O2 dissolves particularly well in the hydrophobic lipid phase, and CrOx is highly hydrophilic. A helical pitch of 3.67 was used to define helical regions (Fig. 3B). This periodicity corresponds to an 11/3 helix, which has been proposed to better conform to the curvature of the periphery of the reconstituted HDL disc and arrange the hydrophobic and charged residues around the helical axis in comparison to a 3.6 helical pitch (23). The SDSL-EPR analysis of lipid-bound apoA-I suggests that residues 13-38 and 49-98 form two individual {alpha}-helices, and that the intervening residues display {alpha}-helical character (residues 43-47). The helical wheel display (Fig. 3C) shows that the distribution of hydrophobic and charged residues around the helical axis is in agreement with the expected amphipathic character of helices in lipid-bound apoA-I.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
The first 90 amino acids of apoA-I compose a unique feature of this molecule. The distinctiveness of this region is highlighted by the presence of proteolytically derived N-terminal fragments (amino acids 1 to ~83) of apoA-I within senile amyloid plaques. Interestingly, the first 43 amino acids of apoA-I are encoded by exon 3, which is the most highly conserved region of apoA-I, whereas the remainder of apoA-I is encoded by exon 4 (4). The structure of the apoA-I gene suggests that this region bears a critical role distinct from the remainder of apoA-I. Furthermore, lipid-free apoA-I lacking residues 1-43 adopts a conformation resembling lipid-bound apoA-I (8, 9). Thus it has been hypothesized that these residues serve to stabilize the compact lipid-free conformation by protecting a latent lipid-binding domain, available only after initial lipid interaction (8).


Figure 3
View larger version (38K):
[in this window]
[in a new window]

 
FIGURE 3.
Secondary structure analysis of lipid-bound apoA-I. Spin-labeled apoA-I mutant proteins in reconstituted HDL discs were analyzed by EPR. A, spectra were compared between lipid-bound (red) and lipid-free (black) apoA-I mutants. B, the accessibility parameters for polar ({pi}CrOx) and non-polar ({pi}O2) was used to calculate the contrast function {Phi} (filled squares), a measure of the hydrophobicity of the immediate environment to a spin-labeled side chain, which is plotted versus residue number. C, a periodicity of 3.67 residues/turn (23) was used to identify the regions displaying {alpha}-helical character and for making the helical projection. The color code is black for hydrophobic (Met, Ile, Leu, Val, Phe, Tyr, Trp, Ala), orange for polar and uncharged (Ser, Thr, Asn, Gln), red for negatively charged (Asp, Glu), and blue for positively charged (Lys, His, Arg) residues. Glycine residues are shown in green.

 
Although the majority of positions throughout apoA-I display dynamics and molecular accessibility that is consistent with the recently solved crystal structure (16), results from EPR analysis suggest the conformation of the N-terminal domain in solution diverge significantly from the crystalline state. The first 90 amino acids in the crystal structure compose of two long {alpha}-helices flanked by loop regions, composing half of a four-helix bundle. However, lipid-poor apolipoproteins are in general noted for their dynamic properties, especially at their termini, and thus the highly ordered structure of crystalline apoA-I may not be representative of a prevalent conformer in solution. Because the thermodynamics of lipid binding are frequently driven by reorganization of secondary and tertiary structural elements, mapping the dynamics of the apoA-I polypeptide at its N-terminal region is an important step in elucidating the mechanism of lipid recognition and lipid-driven reorganization.

As shown recently with the KvAP potassium channel (24) and the MsbA multi-drug resistance protein (25), EPR of site-directed spin labels is useful for identifying conformers in solution that may not be observable when the protein is in a crystalline state. Such discrepancies are not entirely unexpected for apolipoproteins, the global conformational rearrangements of which require a dynamic lipid-free state for lipid sensing and structural conversion. In particular, the EPR data complement the crystal structure by identifying regions involved in hinge bending and misfolding (6, 7) but also in describing the secondary structure, dynamics, and arrangement of specific domains (3, 26, 27).


Figure 4
View larger version (39K):
[in this window]
[in a new window]

 
FIGURE 4.
Model of apoA-I solution structure. A, the previously described structure of crystalline apoA-I (16) is shown. The region (residues 14-98) analyzed in this study is highlighted in bronze. B, the crystal structure was used as a template to model the soluble structure of the apoA-I N terminus. Blue color indicates residues for which the secondary and/or tertiary structure was altered based on the structural information gained from the EPR analysis. The regions where the EPR data is in agreement with the crystal structure are shown in green. The side chains of residues 26, 44, 64, and 167, which are all suggested to be in the central plane of the structure, are shown in red. The structure of the remainder of the protein (residues 99-243) was unchanged in this presentation.

 
The dynamic nature of the N-terminal domain of apoA-I is evident from the appearance of more than one component in the majority of EPR spectra from sites within this region. Thus we find regions within both the C-(3) and N-terminal domains display conformational heterogeneity, consistent with two states in equilibrium. Our model for secondary structure in the N terminus of lipid-free apoA-I is based on the accessibility of side chains to paramagnetic relaxers (prod) and side chain mobility ({delta}-1). In the case of the former, the values will reflect the most predominant conformational state, whereas the simple {delta}-1 evaluation of side chain mobility may over-represent the more dynamic species when considering comparable populations of restricted and mobile side chains. The general agreement of the parameters (prod and {delta}-1) as a function of N-terminal sequence position, along with the identification of sites displaying dipolar interaction, is reflected in the model shown in Fig. 4. Here the structure of the ground-state crystal conformer was modified according to the EPR results to produce a time-averaged conformer of lipid-free apoA-I in solution (Fig. 4B).

The most distinguishing feature between the crystal structure (16) and the EPR-based solution model is the secondary structure content in the N-terminal domain. The assignment of beta-strand secondary structure in lipid-free apoA-I is in agreement with circular dichroism (CD) measurements of the protein in solution (28, 29). Although the crystal structure of apoA-I provides the basis for an elegant model of nascent HDL formation, the fixed ground-state conformation of crystal structure does not reflect the substantial conformational dynamics inherent to apoA-I in solution. For example, the thermodynamics of folding suggest the protein experiences a loosely packed molten globule in solution (30).

Other features of lipid-free apoA-I in solution are not apparent from the crystal structure. These include sites of protease sensitivity in the N-terminal domain (31), the environment of tryptophan residues within the protein (32), and a beta-strand secondary structure content on the order of 10% determined by CD spectroscopy (28, 29). In addition, the {alpha}-helical content of lipid-free apoA-I is measured to be in the range of 45-58% (21), much lower than the 82% observed in the crystal structure (16). The secondary structure content of the crystal structure resembles more the lipid-bound structure (~70-78%) (33) and is in notable agreement with the secondary structure of lipid-bound apoA-I presented in this study. An additional detail not reported in the crystal structure is derived from the relatively high motional freedom of residues 33-44 in both lipid-free and lipid-bound states. This suggests these residues reside within a flexible linker region, consistent with NMR structure analysis of apoA-I in a lipid-mimetic solvent (34). It is noteworthy that in the short segment of beta-strand structure we identify, the N terminus of apoA-I is similar in length to the beta-strand we observe in its C terminus (3). Ongoing studies in our group and elsewhere (28) are exploring the potential of these regions to participate in inter- or intra-domain interaction.

The antiparallel association apoA-I in solution facilitates identification of positions that fall within a central plane of the molecule. In our previous study (3), we found position 167 resides near the center of a long helix that is followed by a flexible loop, an arrangement present in the crystal structure of apoA-I (16). EPR of site-directed spin labels has now been used to examine nearly all sequence positions within N-terminal (1-90) and C-terminal (160-240) regions of apoA-I. In each study we have identified three to four sites that display a weak dipolar coupling as determined from a broadening of the continuous wave EPR spectrum, with the spectra from all other positions in these regions free of dipolar broadening. A similar occurrence of weakly interacting sites is observed in the central one-third of the protein5. The sporadic appearance of self-interacting sites throughout the sequence of apoA-I reflects an antiparallel arrangement of apoA-I dimers, whereas the absence of any strong coupling suggests a loosely associated oligomer, a finding consistent with earlier measurements showing apoA-I in solution exists in a dynamic equilibrium of monomers, dimers, and higher order oligomers (18).

In summary, EPR spectroscopy of site-directed spin labels reveals a dynamic N-terminal domain that is heterogeneous in its secondary structure. To achieve its conformation on the nascent HDL particle, this region converts to a more homogenous structure. In this lipid-bound state, the N-terminal region of apoA-I adopts an elongated helix on the particle surface, where its hydrophobic face partitioned into an aliphatic environment. Dynamic regions in apolipoproteins play a key role in lipid sensing and structural conversion (3). Thus these findings provide important insights into the thermodynamics of lipid binding and the associated structural rearrangements that occur in apoA-I and related apolipoproteins.


    FOOTNOTES
 
* This work was supported in part by the National Institutes of Health Grants HL077268 and HL078615 and by the American Heart Association Scientist Development Grant 0235222N. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

1 Recipient of fellowships from the Sweden-America Foundation, the Bengt Lundqvist Foundation, and the Foundation Blanceflor Boncompagni-Lu-dovisi, neé Bildt. Back

2 To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Medicine, University of California, Davis, CA 95616. Tel.: 530-754-7583; Fax: 530-752-3516; E-mail: jcvoss{at}ucdavis.edu.

3 The abbreviations used are: HDL, high density lipoprotein; apoA-I, apolipoprotein A-I; CD, circular dichroism; CrOx, chromium oxalate; EPR, electron paramagnetic resonance; MTS-SL, methane thiosulfonate spin label; NMR, nuclear magnetic resonance; POPC, 1-palmitoyl-2-oleoyl-sn-glycerophosphocholine; SDSL, site-directed spin label; TBS, Tris-buffered saline. Back

4 Pro-66 was not substituted in order to preserve its unique backbone conformation. Thr-79 was omitted due to poor expression. Back

5 J. O. Lagerstedt, M. S. Budamagunta, M. N. Oda, and J. C. Voss, unpublished data. Back


    ACKNOWLEDGMENTS
 
We thank Dr. L. M. Roberts (California State University, Sacramento) for insightful comments and suggestions to the manuscript. This investigation was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 RR-12088-01 from the National Center for Research Resources, National Institutes of Health.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Linsel-Nitschke, P., and Tall, A. R. (2005) Nat. Rev. Drug Discov. 4, 193-205[CrossRef][Medline] [Order article via Infotrieve]
  2. Marcel, Y. L., and Kiss, R. S. (2003) Curr. Opin. Lipidol. 14, 151-157[CrossRef][Medline] [Order article via Infotrieve]
  3. Oda, M. N., Forte, T. M., Ryan, R. O., and Voss, J. C. (2003) Nat. Struct. Biol. 10, 455-460[CrossRef][Medline] [Order article via Infotrieve]
  4. Li, W. H., Tanimura, M., Luo, C. C., Datta, S., and Chan, L. (1988) J. Lipid Res. 29, 245-271[Medline] [Order article via Infotrieve]
  5. Frank, P. G., and Marcel, Y. L. (2000) J. Lipid Res. 41, 853-872[Abstract/Free Full Text]
  6. Joy, T., Wang, J., Hahn, A., and Hegele, R. A. (2003) Clin. Biochem. 36, 641-645[CrossRef][Medline] [Order article via Infotrieve]
  7. Andreola, A., Bellotti, V., Giorgetti, S., Mangione, P., Obici, L., Stoppini, M., Torres, J., Monzani, E., Merlini, G., and Sunde, M. (2003) J. Biol. Chem. 278, 2444-2451[Abstract/Free Full Text]
  8. Rogers, D. P., Brouillette, C. G., Engler, J. A., Tendian, S. W., Roberts, L., Mishra, V. K., Anantharamaiah, G. M., Lund-Katz, S., Phillips, M. C., and Ray, M. J. (1997) Biochemistry 36, 288-300[CrossRef][Medline] [Order article via Infotrieve]
  9. Borhani, D. W., Rogers, D. P., Engler, J. A., and Brouillette, C. G. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 12291-12296[Abstract/Free Full Text]
  10. Ryan, R. O., Forte, T. M., and Oda, M. N. (2003) Protein Expr. Purif. 27, 98-103[CrossRef][Medline] [Order article via Infotrieve]
  11. Nichols, A. V., Gong, E. L., Blanche, P. J., and Forte, T. M. (1983) Biochim. Biophys. Acta 750, 353-364[Medline] [Order article via Infotrieve]
  12. Nichols, A. V., Gong, E. L., Blanche, P. J., Forte, T. M., and Shore, V. G. (1987) J. Lipid Res. 28, 719-732[Abstract]
  13. Froncisz, W., and Hyde, J. S. (1982) J. Magn. Reson. 47, 515-521
  14. Hubbell, W. L., Froncisz, W., and Hyde, J. S. (1987) Rev. Sci. Instrum. 58, 1879-1886
  15. Oh, K. J., Altenbach, C., Collier, R. J., and Hubbell, W. L. (2000) Methods Mol. Biol. 145, 147-169[Medline] [Order article via Infotrieve]
  16. Ajees, A. A., Anantharamaiah, G. M., Mishra, V. K., Hussain, M. M., and Murthy, H. M. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 2126-2131[Abstract/Free Full Text]
  17. Hubbell, W. L., Mchaourab, H. A., Altenbach, C., and Lietzow, M. A. (1996) Structure 4, 779-783[Medline] [Order article via Infotrieve]
  18. Vitello, L. B., and Scanu, A. M. (1976) J. Biol. Chem. 251, 1131-1136[Abstract/Free Full Text]
  19. Likhtenshtein, G. I. (1993) Biophysical Labeling Methods in Molecular Biology, Cambridge University Press, NY
  20. Kokorin, A. I., Zamaraev, K. I., Grigorian, G. L., Ivanov, V. P., and Rozantsev, E. G. (1972) Biofizika 17, 34-41[Medline] [Order article via Infotrieve]
  21. Davidson, W. S., and Silva, R. A. (2005) Curr. Opin. Lipidol. 16, 295-300[Medline] [Order article via Infotrieve]
  22. Davidson, W. S., Hazlett, T., Mantulin, W. W., and Jonas, A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 13605-13610[Abstract/Free Full Text]
  23. Segrest, J. P., Jones, M. K., Klon, A. E., Sheldahl, C. J., Hellinger, M., De Loof, H., and Harvey, S. C. (1999) J. Biol. Chem. 274, 31755-31758[Abstract/Free Full Text]
  24. Cuello, L. G., Cortes, D. M., and Perozo, E. (2004) Science 306, 491-495[Abstract/Free Full Text]
  25. Dong, J., Yang, G., and McHaourab, H. S. (2005) Science 308, 1023-1028[Abstract/Free Full Text]
  26. Martin, D. D., Budamagunta, M. S., Ryan, R. O., Voss, J. C., and Oda, M. N. (2006) J. Biol. Chem. 281, 20418-20426[Abstract/Free Full Text]
  27. Hatters, D. M., Budamagunta, M. S., Voss, J. C., and Weisgraber, K. H. (2005) J. Biol. Chem. 280, 34288-34295[Abstract/Free Full Text]
  28. Silva, R. A., Hilliard, G. M., Fang, J., Macha, S., and Davidson, W. S. (2005) Biochemistry 44, 2759-2769[CrossRef][Medline] [Order article via Infotrieve]
  29. Brubaker, G., Peng, D. Q., Somerlot, B., Abdollahian, D. J., and Smith, J. D. (2006) Biochim. Biophys. Acta 1761, 64-72[Medline] [Order article via Infotrieve]
  30. Gursky, O., and Atkinson, D. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 2991-2995[Abstract/Free Full Text]
  31. Roberts, L. M., Ray, M. J., Shih, T. W., Hayden, E., Reader, M. M., and Brouillette, C. G. (1997) Biochemistry 36, 7615-7624[CrossRef][Medline] [Order article via Infotrieve]
  32. Davidson, W. S., Arnvig-McGuire, K., Kennedy, A., Kosman, J., Hazlett, T. L., and Jonas, A. (1999) Biochemistry 38, 14387-14395[CrossRef][Medline] [Order article via Infotrieve]
  33. Saito, H., Dhanasekaran, P., Nguyen, D., Deridder, E., Holvoet, P., Lund-Katz, S., and Phillips, M. C. (2004) J. Biol. Chem. 279, 20974-20981[Abstract/Free Full Text]
  34. Okon, M., Frank, P. G., Marcel, Y. L., and Cushley, R. J. (2001) FEBS Lett. 487, 390-396[CrossRef][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
M. J. Thomas, S. Bhat, and M. G. Sorci-Thomas
Three-dimensional models of HDL apoA-I: implications for its assembly and function
J. Lipid Res., September 1, 2008; 49(9): 1875 - 1883.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. R. Tubb, R. A. G. D. Silva, J. Fang, P. Tso, and W. S. Davidson
A Three-dimensional Homology Model of Lipid-free Apolipoprotein A-IV Using Cross-linking and Mass Spectrometry
J. Biol. Chem., June 20, 2008; 283(25): 17314 - 17323.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. S. Davidson and T. B. Thompson
The Structure of Apolipoprotein A-I in High Density Lipoproteins
J. Biol. Chem., August 3, 2007; 282(31): 22249 - 22253.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/12/9143    most recent
M608717200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lagerstedt, J. O.
Right arrow Articles by Voss, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lagerstedt, J. O.
Right arrow Articles by Voss, J. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.